Stolichki

Stolichki, also known by its alias, is a retail pharmacy chain headquartered in Bulgaria that operates a network of stores in Russia, including locations in the Moscow area. It provides pharmaceutical products and services such as prescription dispensing, over‑the‑counter medicines, loyalty programmes, and point‑of‑sale transactions. The chain’s core business is to deliver healthcare goods through physical outlets that serve local communities. Its activities are centred on retail pharmacy operations within the Russian market.

According to the July 29 2025 cyber incident, Stolichki maintains a substantial footprint with more than 1,100 pharmacy locations spread across over 80 cities. This scale indicates a broad market reach that encompasses numerous regional markets within the country. The attack disrupted digital infrastructure at many of these sites, affecting access to prescriptions, loyalty programmes, and point‑of‑sale systems. The resulting outage forced the temporary suspension of operations and placed some staff on unpaid leave while restoration efforts proceeded.

Stolichki’s distinguishing attributes include its specialisation in retail pharmacy and its role as a provider of pharmaceutical goods and services supported by its extensive store network. The chain has demonstrated the capacity to manage a geographically dispersed store network while maintaining integrated systems for inventory, sales, and customer loyalty. Prior to the cyberattack, Stolichki shared common ownership with the Neopharm pharmacy chain; both were previously controlled by businessman Yevgeny Nifantiev before his stake was transferred to the Zdravinvest fund following sanctions linked to Ukraine.

Structural notes reveal that Stolichki’s headquarters are located in Bulgaria, while its operational base includes stores in Moscow. Ownership details show that after the sanctions‑related shift, the controlling interest moved from Yevgeny Nifantiev to the Zdravinvest fund, altering the chain’s parent‑company structure.